TALEGRIA Tablets Quiz and Flashcards

Study Notes

TALEGRIA 5: Yellow coloured, oval shape, biconvex with bevelled edge, film-coated tablets debossed “897” on one side and plain on the other side.
TALEGRIA 20: Yellow coloured, oval shape, biconvex with bevelled edge, film-coated tablets debossed “899” on one side and plain on the other side.

The recommended dose is 5 mg taken once a day at approximately the same time of day.
The recommended maximum dose of TALEGRIA is 20 mg taken prior to anticipated sexual activity and without regard to food.
TALEGRIA 20 mg can be taken up to 36 hours and as early as 16 minutes prior to sexual activity.
Patients may initiate sexual activity at varying time points relative to dosing in order to determine their own optimal window of responsiveness.
The maximum recommended dosing frequency of TALEGRIA is once per day.

Dosage adjustments are not required in patients with mild or moderate renal impairment.
Once-daily dosing of TALEGRIA is not recommended in patients with severe renal impairment.
TALEGRIA is not indicated for children under 18 years.

Hypersensitivity to the active substance, tadalafil, or to any of the excipients of TALEGRIA.
Administration of TALEGRIA to patients who are using any form of organic nitrate.
Patients with severe hepatic insufficiency (Child-Pugh Class C).
Previous experience of loss of vision in one or both eyes because of non-arteritic anterior ischaemic optic neuropathy (NAION).
Previous experience of unilateral or bilateral decrease or loss of hearing with or without associated vestibular symptoms.

A medical history and physical examination should be undertaken to diagnose erectile dysfunction and determine potential underlying causes.
Sexual activity carries a potential cardiac risk for patients with pre-existing cardiovascular disease.
Prior to initiating any treatment for erectile dysfunction, medical practitioners should consider the cardiovascular status of their patients.
Tadalifil has vasodilator properties, resulting in mild and transient decreases in blood pressure.
TALEGRIA should not be used in men with cardiac disease for whom sexual activity is inadvisable.
It is not known if tadalafil is effective in patients who have undergone pelvic surgery or radical non nerve-sparing prostatectomy.